Work

S2061 Risk of Clostridioides difficile Infection Following Rifaximin Treatment for Small Intestinal Bacterial Overgrowth

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001135704.58458.11

Authors: Abdelrahman Yousef, Niven Wang, Mahmoud Yousef, Khaled Elfert, Ahmed Telbany, Daniel Peverini, Shannon Henry, Eliseo Castillo, Aleksandr Birg

Language: English

Topic: Clostridium difficile and Clostridium perfringens research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417197261

Cites:

Cited by:

Related to: